United Bank (Virginia)’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-25,200
| Closed | -$25.7K | – | 154 |
|
|
2024
Q1 | $25.7K | Hold |
25,200
| – | – | ﹤0.01% | 145 |
|
|
2023
Q4 | $14.4K | Buy |
25,200
+5,200
| +26% | +$2.96K | ﹤0.01% | 147 |
|
|
2023
Q3 | $20.8K | Buy |
20,000
+9,795
| +96% | +$10.2K | ﹤0.01% | 144 |
|
|
2023
Q2 | $14.4K | Hold |
10,205
| – | – | ﹤0.01% | 154 |
|
|
2023
Q1 | $16.2K | Hold |
10,205
| – | – | ﹤0.01% | 158 |
|
|
2022
Q4 | $14.9K | Buy |
+10,205
| New | +$14.9K | ﹤0.01% | 156 |
|